Showing results (231-240 of 241) with videos related to
Sort By:
Pageof 25
Molecular Pharmacology|November 1, 1994
Biological properties of the benzodiazepine amidine derivative L-740,093, a cholecystokinin-B/gastrin receptor antagonist with high affinity in vitro and high potency in vivoS Patel, A J Smith, K L Chapman, et al.Journal of Human Hypertension|May 1, 1997
Therapy in old patients with isolated systolic hypertension: fourth progress report on the Syst-Eur trialR Antikainen, J Tuomilehto, L Thijs, et al.Bioorganic & Medicinal Chemistry|December 5, 1998
Substituted pyrazoles as novel selective ligands for the human dopamine D4 receptorS Bourrain, I Collins, J G Neduvelil, et al.European Journal of Clinical Nutrition|October 28, 2018
Factors associated with serum 25-hydroxyvitamin D concentrations in older people in Europe: the EUREYE studyClaire Casey, Jayne V Woodside, Ann McGinty, et al.Journal of Medicinal Chemistry|July 20, 1999
1-(3-Cyanobenzylpiperidin-4-yl)-5-methyl-4-phenyl-1, 3-dihydroimidazol-2-one: a selective high-affinity antagonist for the human dopamine D(4) receptor with excellent selectivity over ion channelsR W Carling, K W Moore, C R Moyes, et al.Ophthalmology|March 6, 2007
Cigarette smoking and age-related macular degeneration in the EUREYE StudyU Chakravarthy, C Augood, G C Bentham, et al.The British Journal of Ophthalmology|May 12, 2009
Association of diabetes with age-related macular degeneration in the EUREYE studyF Topouzis, E Anastasopoulos, C Augood, et al.European Journal of Nutrition|October 26, 2012
Factors associated with serum/plasma concentrations of vitamins A, C, E and carotenoids in older people throughout Europe: the EUREYE studyJ V Woodside, I S Young, S E C M Gilchrist, et al.Journal of Hypertension|October 30, 1998
Correlates of cognitive status of old patients with isolated systolic hypertension: the Syst-Eur Vascular Dementia ProjectM L Seux, L Thijs, F Forette, et al.Journal of Medicinal Chemistry|February 16, 1996
Controlled modification of acidity in cholecystokinin B receptor antagonists: N-(1,4-benzodiazepin-3-yl)-N'-[3-(tetrazol-5-ylamino) phenyl]ureasJ L Castro, R G Ball, H B Broughton, et al.Pageof 25